Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Issa Scolds FDA On Failure To Inspect McNeil Plant

This article was originally published in The Tan Sheet

Executive Summary

A key House committee chairman questions why FDA has not inspected McNeil Consumer Healthcare's Puerto Rico plant despite a requirement that the Johnson & Johnson business pay the agency's costs.

You may also be interested in...



J&J Hears Consent Decree Echoes In Litigation From ‘Silent’ Motrin Recall

J&J intends to appeal to Oregon’s Supreme Court the state appellate court’s decision that the absence of proof of harm to consumers from sales of Motrin 200mg that failed to meet dissolution standards does not preclude unfair trade litigation filed by the state attorney general.

J&J Hears Consent Decree Echoes In Litigation From ‘Silent’ Motrin Recall

J&J intends to appeal to Oregon’s Supreme Court the state appellate court’s decision that the absence of proof of harm to consumers from sales of Motrin 200mg that failed to meet dissolution standards does not preclude unfair trade litigation filed by the state attorney general.

FDA’s IT Overhaul Stagnating Despite Massive Spending, GAO Finds

The agency has not been able to get rid of outdated IT systems despite spending more than $160 million to date on a program designed to do that among other goals.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel